John Sharp

7PUBLICATIONS

88CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 18, 2026

Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma.

|Apr 27, 2026

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers.

|Feb 26, 2026

Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.

John Sharp, Paolo Strati, Subodh Bhatta

|Feb 04, 2026

Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate.

Zachary J Arnold, Jordan Lundberg, Tracy Wiczer

|Jan 06, 2026

Juan Pablo Alderuccio, Diva Baggio, Sunwoo Han

|Oct 27, 2025

Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

Pageof 2

Frequent Collaborators

Narendranath Epperla

Natalie S Grover

Timothy J Voorhees

David Bond

Yazeed Sawalha

John Reneau

Jonathan E Brammer

Joanna M Rhodes

Thomas A Ollila

Danielle S Wallace

Frequent Collaborators

Narendranath Epperla

Natalie S Grover

Timothy J Voorhees

David Bond